ghk cu peptide injection prescription GHK-Cu Injectable GHK-Cu Peptide Injection Before and

Designed to restore a more youthful, revitalized appearance

Analytical Identity Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5) is a naturally occurring copper-binding tripeptide - glycyl-L-histidyl-L-lysine chelated to a divalent copper ion (Cu2+) - first identified in human plasma, where its concentration has been reported to decline with age, and later characterized in saliva and other biological fluids

DSIP-CBBBP fusion peptide and DSIP treatments demonstrated even more significant increases in neuron density compared to the model group, emphasizing the potential of these treatments in counteracting neuronal loss associated with insomnia

Research interest nonetheless expanded considerably through the 1980s and 1990s, as investigators began exploring DSIP's broader neuroendocrine roles, including its interactions with the HPA axis, circadian timing systems, and stress-response pathways, establishing the compound as a multifunctional regulatory neuropeptide whose biological significance extends well beyond its original sleep-focused characterization

Clinical trials demonstrate that GHK-Cu skin serum can help reduce the effects of UV radiation

Each vial contains 50mg of lyophilized GHK-Cu in a sealed 3mL glass vial, verified through Mile High Compounds three-tier quality protocol : 7x independent third-party analytical testing, 4-vial batch conformity verification, and comprehensive heavy metal screening